Metabolic Memory Phenomenon and Accumulation of Peroxynitrite in Retinal Capillaries by Kowluru, Renu A. et al.
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2007, Article ID 21976, 7 pages
doi:10.1155/2007/21976
ResearchArticle
Metabolic Memory Phenomenon and Accumulation of
Peroxynitrite in Retinal Capillaries
Renu A. Kowluru, Mamta Kanwar, and Alexander Kennedy
Received 26 February 2007; Accepted 17 April 2007
Recommended by Subrata Chakrabarti
Aim. Diabetic retinopathy resists reversal after good glycemic control (GC) is reinitiated, and preexisting damage at the time of
intervention is considered as the major factor in determining the outcome of the GC. This study is to investigate the role of perox-
ynitrite accumulation in the retinal capillaries in the failure of retinopathy to reverse after reestablishment of GC, and to determine
the eﬀect of this reversal on the activity of the enzyme responsible for scavenging mitochondrial superoxide, MnSOD. Methods.
In streptozotocin-diabetic rats, 6 months of poor glycemic control (PC, glycated hemoglobin, GHb > 12.0%) was followed by 6
additional months of GC (GHb about 6%). The trypsin-digested retinal microvessels were prepared for immunostaining of ni-
trotyrosine (a measure of peroxynitrite) and for counting the number of acellular capillaries (a measure of histopathology). The
retina from the other eye was used to quantify nitrotyrosine concentration, MnSOD activity and the total antioxidant capacity. Re-
sults. Reversal of hyperglycemia after 6 months of PC had no signiﬁcant eﬀect on nitrotyrosine concentration in the retina, on the
nitrotyrosine-positive retinal capillary cells and on the number of acellular capillaries; the values were similar in PC-GC and PC
groups. In the same rats retinal MnSOD activity remained inhibited and the total antioxidant capacity was subnormal 6 months
after cessation of PC. Conclusions. Peroxynitrite accumulation in the retinal microvasculature, the site of histopathology, fails to
normalize after reversal of hyperglycemia, and superoxide remains inadequately scavenged. This failure of reversal of peroxynitrite
accumulation could be, in part, responsible for the resistance of diabetic retinopathy to reverse after termination of PC.
Copyright © 2007 Renu A. Kowluru et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
The DCCT and the follow-up EDIC studies have shown that
instituting tight glycemic control in diabetic patients does
not immediately beneﬁt the progression of retinopathy, and
the beneﬁts of good control persist beyond the period of
good glycemic control [1, 2]. This phenomenon, commonly
termed as “metabolic memory”, is stored early in the course
of diabetes, and glycemic control initiated prior to the onset
of overt pathology has the most profound long-term impact.
The persistence or progression of hyperglycemia-induced
microvascular alterations during subsequent periods of nor-
mal glucose suggests that previous high or low glucose levels
imprint their eﬀects, and could result either in resistance of
themicrovascularcomplicationtohalt,orhavealong-lasting
beneﬁt of good glycemic control [3, 4].
Hyperglycemia, per se, is considered as the initiating fac-
torinthedevelopmentofretinopathy[5],andvariousretinal
abnormalities induced by hyperglycemia, including elevated
polyol pathway activity, increased nonenzymatic glycation,
and advanced glycation end products, oxidative stress, and
protein kinase C activity [6–9], evidently contribute to the
development of the microangiopathy. Superoxide and nitric
oxide (NO) levels are elevated in the retina and its capillary
cells in diabetes [9–11]. Superoxide anion and NO interact
formingperoxynitrite.Peroxynitrite,althoughnotafreerad-
ical, can induce lipid and protein oxidation, and nitration
of proteins [12]. The expression of nitrotyrosylated proteins
is elevated in the retina early in the pathogenesis of diabetic
retinopathy, and remains elevated when the pathology is de-
veloping [10, 13, 14].
The metabolic memory phenomenon is also observed in
animal models of diabetic complications; retinopathy con-
tinues to progress for a considerable period even after hyper-
glycemia is corrected in dogs [15], and islet transplantation
after several months of diabetes in rats arrests the progres-
sion of retinopathy less eﬀectively than if intervention oc-
curs after only a few weeks of diabetes [16]. We have shown
that reinstitution of good glycemic control after 2 months
of poor glycemic control in rats inhibits elevations in reti-
nal lipid peroxides and NO levels, but if good glycemic con-
trol is reinstituted after 6 months of poor glycemic control,2 Experimental Diabetes Research
oxidative stress and nitrative stress remain elevated in the
retina [17]. Further, reinstitution of normal glycemia after
6 months of poor glycemic control does not inhibit the ac-
tivation of apoptosis execution enzyme, caspase-3, and the
nuclear transcription factor in the retina [18]. However, the
exact mechanism of this metabolic phenomenon remains to
be elucidated.
The retina is a complex tissue with multiple cell types. In
the present study, we have investigated the eﬀect of reestab-
lishment of good glycemic control in diabetic rats on perox-
ynitrite accumulation in the capillaries of the retina, the ma-
jor site of histopathology in diabetes, and have compared the
nitrotyrosine staining with the appearance of early histologi-
callesions.Eﬀectofreestablishmentofgoodglycemiccontrol
was also determined on the activity of the enzyme responsi-
ble for scavenging superoxide, one of the major components
of peroxynitrite formation.
2. METHODS
2.1. Animals
Lewis rats (male, 200g) were assigned to normal or diabetic
groups. Diabetes was induced with intraperitoneal injection
of streptozotocin (55mg/kg BW). Diabetic rats were divided
at random among 2 groups according to the intended de-
gree of glycemic control. Group number 1 consisted of rats
that were allowed to remain in poor glycemic control for
12 months (PC), and group number 2 had rats that were
allowed to remain in poor glycemic control for 6 months
and this was followed by good glycemic control for 6 addi-
tional months (PC-GC). A group of rats remained normal
for the entire duration of the experiment. Each group had 10
or more rats.
2.2. Glycemia
All diabetic rats received insulin (NPH); the dose and fre-
quency of insulin were adjusted based on the severity of hy-
perglycemia. The rats in which poor glycemic control was
intended received a single injection of insulin (1-2 units) 4-
5 times a week to prevent ketosis and weight loss, and the
rats in which good control was intended received insulin
twice daily (6-8 units total) to maintain their blood glu-
cose levels below 150mg/dl [18]. The entire rat colony was
housed in metabolism cages. Twenty-four-hour urine sam-
ples were tested daily for glycosuria with Keto-Diastix (Bayer
Corporation, IN), and 2-3 times every week using quantita-
tive methods (Glucose Kit, GAGO-20, Sigma-Aldrich Chem-
icals, St. Louis, MO). Blood glucose was measured once a
week(GlucometerElite,BayerCorporation,IN)andglycated
hemoglobin (GHb) every 2-3 months using a kit from He-
lena Laboratories (Beaumont, TX). The rats received pow-
dered diet (PURINA 5001); their food consumption was
measuredonceandbodyweights2-3timeseveryweek.These
experiments conformed to the ARVO Resolution on Treat-
ment of Animals in Research, as well as to the speciﬁc in-
stitutional guidelines. At the end of the desired duration of
glycemic control, the animals were sacriﬁced by an over-
dose of pentobarbital. One eye from each animal was placed
into buﬀered formalin for isolation of the retinal vasculature
by the trypsin digest technique (described below), and the
othereyewasusedimmediatelytoisolateretinaforbiochem-
ical measurements by gently separating sensory retina from
choroid using a microspatula under a dissecting microscope.
2.3. Retinalmicrovesselsandimmunostaining
Retina was removed from the eyes that were ﬁxed in for-
malin, washed overnight with distilled water, and digested
for 90 minutes with 3% crude trypsin in Tris-HCl buﬀer
(pH 7.8) containing 0.2M sodium ﬂuoride to isolate mi-
crovessels [14, 18]. These trypsin-digested microvessels were
used to localize nitrotyrosine (a biomarker of peroxynitrite
formation), and to count the number of acellular capillar-
ies. Microvessels were air-dried on the slides and mounted
using 50% glycerol. For nitrotyrosine immunostaining, the
preparation was rehydrated with TBS (50mM Tris-HCl, pH
7.5 and 150mM NaCl), and incubated with 3% H2O2 for
15 minutes, followed by rinsing with TBS to remove excess
H2O2. The samples were blocked with 5% goat serum for
1 hour at room temperature followed by incubation with
antinitrotyrosine antibody (Upstate, Lake Placid, NY). The
slides were washed 3 × 10 minutes with TBS, and incu-
bated with peroxidase-conjugated secondary antibody (goat
a n t i r a b b i t )f o r1h o u ra tr o o mt e m p e r a t u r e .T h em i c r o v e s -
sels were washed 3 × 10 minutes with TBS, and stained with
aminoethylcarbazole solution (in 0.1M acetate buﬀer, pH
5.2, containing 0.05% H2O2) for 40 minutes. The slides were
counterstained with Gill’s Hematoxylin solution for 2 min-
utes, rinsed with TBS, and visualized under a microscope.
The numbers of nitrotyrosine positive cells and acellu-
larcapillarieswerecountedinmultiplemidretinalﬁelds(one
ﬁeld adjacent to each of the 5 to 7 retinal arterioles radiating
out from the optic disc) and expressed per mm2 of retinal
area examined [9, 14].
2.4. Nitrotyrosineconcentrationintheretina
Nitrotyrosine concentration was quantiﬁed by enzyme im-
munoassayusingaNitrotyrosine-EIAkitfromOxisResearch
(Portland, OR) as described in [14, 19]. Nitrotyrosine stan-
dard or retinal homogenates were incubated with nitroty-
rosine antibody in the microplate for one hour, and an-
tinitrotyrosine antibody for one hour; this was followed by
incubation with streptavidin peroxidase for one hour. The
samples were incubated with tetramethylbenzidine substrate
for 30 minutes, and the reaction was stopped by 2.0M cit-
ric acid. The formation of yellow product was measured at
450nm. The assay was sensitive to concentrations as low as
0.05pmoles of nitrotyrosine.
2.5. EnzymeactivityofMnSOD
TheactivityofSODwasmeasuredintheretinausing5–10μg
protein by a method that utilizes tetrazolium salt to quan-
tify superoxide radicals generated by xanthine oxidase andRenu A. Kowluru et al. 3
hypoxanthine. MnSOD activity was determined by perform-
ing the assay in the presence of potassium cyanide to inhibit
Cu-ZnSOD,andtheresidualMnSODactivitywascalculated
[19].
2.6. Totalantioxidantcapacity
The total antioxidant capacity of the retina was measured
using a kit from Cayman Chemical (Ann Arbor, MI) as de-
scribedin[19].Theassayisbasedontheabilityofthesample
to inhibit oxidation of 2,2’-azino-di-[3-ethylbenzthiazoline
sulfonate] R (ABTS) by metmyoglobin; the antioxidants in
the sample cause decrease in absorbance at 750nm, and that
represents the amount of ABTSR+ produced. Each measure-
ment was made in duplicate using about 5μg of retinal pro-
tein.
2.7. Statisticalanalysis
T h er e s u l t sa r er e p o r t e da sm e a n± SD and analyzed statis-
tically using the nonparametric Kruskal-Wallis test followed
byMann-Whitneytestformultiplegroupcomparisons.Sim-
ilar conclusions were reached also by using ANOVA with
F i s h e ro rT u k e y .
3. RESULTS
3.1. Glycemia
The rats in PC group, as expected, had severe hyperglycemia;
their GHb values were about 12% throughout the 12 months
duration compared to less than 6% in the rats that remained
normal for the entire duration of the experiment (Table 1).
The GHb values in the rats in PC-GC group were around
12% before good glycemic control was initiated, but de-
creased by 2 fold after reinstitution of good glycemic control
in those rats.
In the same PC-GC rats, body weight and daily food
consumption before reinstitution of good glycemic control
were statistically similar to those obtained from the rats in
PC group, but became comparable to the normal rats after
reestablishment of good glycemic control (Table 1). Similar
pattern was observed for 24-hour urine excretion (data not
shown).
3.2. Nitrotyrosineandhistopathology
The total nitrotyrosine concentration in the retina was el-
evated by about 30% in the rats that were maintained in
poor glycemic control for the entire duration of the experi-
ment(12months)comparedtotheage-matchednormalrats
(Figure 1). Reestablishment of good glycemic control after 6
months of poor glycemic control failed to decrease nitroty-
rosine levels in the retina; both PC and PC-GC groups had
similar concentrations, and these values were signiﬁcantly
diﬀerent from those obtained from the normal control rats
(P<. 05).
In order to determine nitrotyrosine levels in the retinal
microvasculature,trypsin-digestedmicrovesselswerestained
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Figure 1: Eﬀect of cessation of hyperglycemia on nitrotyrosine lev-
els in the retina. Nitrotyrosine was quantiﬁed in the retinal ho-
mogenateusingaNitrotyrosine-EIAkit.Eachsamplewasmeasured
in duplicate. The ﬁgure represents mean for all SD of 7 rats in nor-
mal, 6 rats in PC, and 8 rats in PC-GC groups. ∗P<. 05 compared
to normal, and #P>. 05 compared to PC.
with the antibodies that detect nitrotyrosine. The number
of nitrotyrosine positive cells was about 2.5 fold higher in
the microvessels prepared from the retina of the rats in PC
group, compared to the rats that remained normal for the
entire duration of the experiment. Six months of poor con-
trolfollowedby6additionalmonthsofgoodcontrol(PC-GC
group) did not produce any beneﬁcial eﬀect on the number
of nitrotyrosine positive capillary cells; the values were simi-
lar in the microvessel preparations from the PC and PC-GC
groups (Figure 2).
The histopathology associated with diabetic retinopathy
was evaluated in the same trypsin-digested retinal microves-
sel preparation. Figure 3 shows that the number of acellular
capillaries was increased by about 4 fold in the retina of rats
inPCgroupcomparedtotheage-matchednormalrats.Rein-
stitution of good glycemic control (PC-GC) failed to provide
any signiﬁcant eﬀect on the number of acellular capillaries in
the retinal vasculature; the number of acellular capillaries re-
mained signiﬁcantly elevated in the PC-GC group compared
to the normal group.
3.3. Superoxidedismutaseactivity
The enzyme activity of MnSOD was inhibited by 50% in the
retinaofratsdiabeticfor12months(PCgroup)comparedto
the age-matched normal rats (Figure 4). Six months of good
glycemic control that followed poor glycemic control did not
reverse the inhibition of MnSOD activity; the enzyme activ-
ity in PC and PC-GC groups was not diﬀerent from each
other (P>. 05).4 Experimental Diabetes Research
Table 1: Reinstitution of good glycemic control and the severity of hyperglycemia. The rats were weighed 2 times a week, and the food
consumption was measured once/week. Glycated hemoglobin was measured every 2 months using a kit from Helena Laboratories. The
values are mean ± SD of 7 rats in normal group and 8 rats each in PC and PC-GC groups. ∗P<. 05 and #P>. 05 compared to normal.
Body weight (g) Food (g/day) Glycated Hemoglobin(%)
Normal 384 ±26 23 ±36 .7 ±0.6
Poor control 281 ±34
∗ 37 ±6∗ 13.3 ±2.2
∗
Poor control 265 ±25
∗ 41 ±9∗ 14.7 ±2.1
∗
↓↓ ↓↓
Good control 334 ±36# 25 ±5# 6.9 ±1.1#
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Figure 2: Eﬀect of reversal of hyperglycemia on nitrotyrosine-
positive capillary cells in the retina. Trypsin-digested retinal mi-
crovessels were immuno-reacted with antinitrityrosine antibody,
and stained with aminoethylcarbazole solution 0.05% H2O2 for 40
minutes. This was followed by counterstaining with Gill’s Hema-
toxylin solution. Nitrotyrosine stained capillary cells were counted
in a masked fashion. The results are obtained from 7–9 rats in each
of the 3 groups. ∗P<. 05 compared to normal, and #P>. 05 com-
pared to PC.
3.4. Totalantioxidantcapacity
The overall antioxidant capacity of the retina, as expected,
decreased by about 25% in the rats that were in the PC group
compared to their age-matched normal rats. Reinstitution
of good glycemic control after 6 months of poor glycemic
control had no beneﬁcial eﬀects on the diabetes-induced de-
crease in the total antioxidant capacity of the retina; the val-
ues obtained from the rats in PC-GC group remained sig-
niﬁcantly lower than the normal rats, and were not diﬀerent
from those obtained in the PC group (Figure 5).
4. DISCUSSION
This is the ﬁrst report demonstrating that peroxynitrite
accumulation in the capillaries of the retina, the site of
histopathology in the development of diabetic retinopathy,
PC-GC PC Normal
0
4
8
12
A
c
e
l
l
u
l
a
r
c
a
p
i
l
l
a
r
i
e
s
/
m
m
2
r
e
t
i
n
a
∗
∗#
Figure3:Reversalofhyperglycemiaandretinalhistopathology.The
number of acellular capillaries was counted in multiple midretinal
ﬁelds in a blinded manner in the trypsin-digested retinal microves-
sels that were used for nitrotyrosine staining. ∗P<. 05 compared to
normal, and #P>. 05 compared to PC.
resists arrest after reinstitution of good glycemic control in
the rats that has followed a period of poor glycemic control.
In the same rats, reversal of hyperglycemia fails to inhibit the
developmentofretinalhistopathology.Thisstronglysuggests
that diabetes-induced nitrative modiﬁcations in the capil-
laries of the retina play an important role in the metabolic
memory phenomenon. These novel ﬁndings from the reti-
nal capillaries are supported by our previous data obtained
from the whole retina demonstrating that retinal oxidative
stressandexpressionofnitrosylatedproteinsremainelevated
7 months after reinstitution of good glycemic control in the
rats that had 6 months of poor glycemic control [17, 18],
and also from experimentally galactosemic rats, another an-
imal model of diabetic retinopathy, showing that the expres-
sion of retinal nitrosylated protein is elevated for at least 1
month of galactose-withdrawal that has followed 2 months
of 30% galactose diet [20]. Further, we also provide evidence
that the reversal of hyperglycemia has no beneﬁcial eﬀects
on the inhibition of the enzyme responsible for scavengingRenu A. Kowluru et al. 5
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Figure 4: Eﬀect of reversal of hyperglycemia on MnSOD enzyme
activity in the retina. Retinal protein (5–10μg) was used to mea-
sureSODactivityusinganassaykit(CaymanChemical,AnnArbor,
MI). MnSOD activity was calculated by subtracting the potassium
cyanide-inhabitable activity from the total SOD activity, and the ac-
tivity obtained from the retina of normal rats was considered as
100%. The values are mean ± SD of 7-8 rats in each group. ∗P<. 05
compared to normal, and #P>. 05 compared to PC.
mitochondrial superoxide, MnSOD, and on the overall an-
tioxidant capacity of the retina.
Our data show that reversal of poor glycemic control
by reinstituting good glycemic control with insulin regimen
had no signiﬁcant eﬀect on the retinal histopathology in
rats. In support, others have shown that islet transplanta-
tion, if performed 12 weeks after induction of diabetes in
rats does not prevent retinal vessel occlusion [16], and re-
institution of good glycemic control for 2.5 years in dogs af-
ter 2.5 years of poor control does not beneﬁt the develop-
ment of diabetic retinopathy [15]. In experimentally galac-
tosemic rats and dogs, withdrawal of galactose after a period
of galactose-diet does not completely prevent the progres-
sion of retinal pathology [21, 22]. Our exciting results show
that in the same retinal microvascular preparation the num-
ber of nitrotyrosine-positive capillary cells does not decline 6
monthsaftergoodglycemiccontrolisreinstituted indiabetic
rats. This is the ﬁrst report suggesting that peroxynitrite ac-
cumulation in retinal capillaries could be contributing to the
failure of retinopathy to reverse.
Peroxynitrite formed by the reaction between superoxide
and NO can attack a wide range of biological targets, includ-
ing proteins and DNA [12]. Peroxynitrite nitrates free tyro-
sine and tyrosine residues in proteins [23]. Nitration of pro-
teins can disrupt protein assembly and functions with pos-
sible pathological consequences [24] ,a n di sp o s t u l a t e dt ob e
involved in the apoptosis of retinal cells [25]. Increased per-
oxynitrite is also associated with various chronic diseases, in-
cludingParkinson’sdisease,Alzheimer’sdisease,anddiabetes
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Figure 5: Eﬀe c to fr e v e r s a lo fh y p e r g l y c e m i ao nt h et o t a la n t i o x i -
dant capacity of the retina. The total antioxidant capacity was mea-
sured in the retina (5–10μg) using a kit from Cayman Chemical,
MIBTS. Each sample was measured in duplicate, and the values are
represented as mean ± SD of 8 normal, 7 PC, and 9 PC-GC rats.
∗P<. 05 compared to normal, and #P>. 05 compared to PC.
[26, 27]. In diabetes the levels of superoxide and NO are el-
evated in the retina [9–11], and the expression of nitrosy-
lated proteins and the concentration of nitrotyrosine are in-
creased [10, 13, 14]. Further, reinstitution of good glycemic
control does not easily reverse diabetes-induced increase in
the protein expression of nitrosylated proteins in the retina
[17]. We demonstrate that diabetes-induced increase in the
nitrotyrosine positive capillary cells, and also the total reti-
nal nitrotyrosine concentration resist reversal after reestab-
lishment of good glycemic control, suggesting that peroxyni-
trite, which starts accumulating in the retinal capillaries dur-
ing poor glycemic conditions, once formed, becomes diﬃ-
cult to reverse. Nitrotyrosine in the retina and its capillary
cells was measured at 12 months duration, however, our pre-
vious results have shown that the duration of diabetes and
the age of the rat (2–14 months) have no signiﬁcant eﬀect
on the increase in retinal oxidative stress and nitrative stress
[9, 13, 17, 18]. In addition, although there is no clearly de-
ﬁned mechanism of removal of nitration, there are some re-
ports showing that the enzyme denitrase can remove the ni-
tro group without degrading the protein [28]. Our results
showing the failure of reversal of nitrotyrosine imply that the
activity of this enzyme could be aﬀected by sustained high
glucose, and is not easily normalized after removal of high
glucose.
Mitochondria are considered as the major source of su-
peroxide production and are subjected to direct attack by re-
active oxygen species (ROS) [29] .S u p e r o x i d ea c ta sac a u s a l
link between elevated glucose and the major vascular com-
plications in diabetes [3] .T h el e v e l so fs u p e r o x i d ea r ee l e -
vated in the retina in diabetes, cytochrome c release from the6 Experimental Diabetes Research
mitochondria to the cytosol is increased, and the mitochon-
drial electron transport chain is impaired [11, 19, 30, 31].
MnSOD is the ﬁrst line of defense; it scavenges superoxide
anion in the mitochondrial matrix by catalyzing dismuta-
tion of superoxide radicals via conversion of superoxide to
hydrogen peroxide and oxygen [32] .M n S O Dp r o t e c t st h e
disruption of mitochondrial membrane potential, and its in-
hibition results in increased superoxide radicals [33]. The
activity of MnSOD is decreased in the retina in diabetes,
its expression is down regulated, and the therapy that in-
hibits the development of retinopathy in diabetes also in-
hibits diabetes-induced decreasein MnSODactivity[19,31].
OverexpressionofMnSODprotectstheretinafromdiabetes-
induced decrease in antioxidant capacity and GSH levels,
and increase in the oxidatively modiﬁed DNA levels imply-
ing that MnSOD could be important in protecting the retina
from diabetes-induced damages [19]. Here we provide data
to show that diabetes-induced inhibition of retinal MnSOD
activity does not reverse 6 months after good glycemic con-
trol is reinstituted. This suggests that superoxide that were
accumulating in excess due to hyperglycemia, continue to be
scavenged inadequately, thus contributing to elevated per-
oxynitrite levels in the retina and its microvasculature. The
reason for this failure of MnSOD inhibition to reverse could
include inactivation of the active site of MnSOD via either
increased nonenzymatic glycation or nitration, or any other
post-translational modiﬁcation that would be diﬃcult to re-
verse [34, 35]. Our results of increased nitrotyrosine levels
in the retina of PC-GC rats suggest that MnSOD could re-
main nitrosylated compromising the scavenging of superox-
ide,andcontributetothepersistentincreasedoxidativestress
even after reinstitution of good glycemic control. Diabetes-
induced decrease in the retinal antioxidant capacity, a mea-
sure of the total protective antioxidant mechanism [36], was
not normalized after reversal of hyperglycemia in rats, sug-
gesting that the failure could be either due to continued in-
creased production of free radicals, or their decreased re-
moval, or both. We have shown that retinal antioxidant ca-
pacityisdecreasedintheretinaindiabetes,andMnSODpro-
tects this diabetes-induced decrease [19]. Thus, the failure
of reversal of inhibition of MnSOD activity after reestablish-
mentofgoodcontrolcouldaccount,inpart,tothedecreased
total antioxidant capacity of the retina. Further, this resis-
tanceofthetotalantioxidantcapacityoftheretinatobecome
normalcouldbeduetosustaineddecreasedlevelsofintracel-
lular antioxidant, GSH. In support, we have shown that the
reinstitution of good glycemic control in diabetic rats does
not producebeneﬁcialeﬀectsinincreasingtheconcentration
of retinal GSH levels [17].
Thus, data presented here strongly suggest that peroxyni-
trite accumulation in the microvasculature of the retina and
impaired scavenging of mitochondrial superoxide could be
important elements in the failure to halt the progression of
diabetic retinopathy. Identifying the abnormalities responsi-
ble for the resistance of retinopathy to reverse after establish-
mentofnormalbloodsugarlevelsshouldrevealnoveltargets
for therapies to prevent the progression of retinopathy in di-
abetic patients.
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